{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Asulacrine_Isethionate",
  "nciThesaurus": {
    "casRegistry": "80841-48-1",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "The isethionate salt of an amsacrine analogue with antineoplastic properties. Asulacrine inhibits the enzyme topoisomerase ll, thereby blocking DNA replication and RNA and protein synthesis.",
    "fdaUniiCode": "649R3P169I",
    "identifier": "C1050",
    "preferredName": "Asulacrine Isethionate",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1968",
      "C582"
    ],
    "synonyms": [
      "9-(2-Methoxy-4-(methylsulfonylamino)phenylamino)-N,5-dimethyl-4-acridinecarboxamide 2-hydroxyethanesulfonate",
      "ASULACRINE ISETHIONATE",
      "Asulacrine Isethionate",
      "CI-921"
    ]
  }
}